肠道菌群与宫颈癌

doi:10.3760/cma.j.cn371439-20230410-00074

摘要/Abstract

摘要：

宫颈癌的发生、发展受到肠道菌群影响，宫颈癌患者与健康女性肠道菌群不同，对肠道菌群进行检测、评价有助于宫颈癌的诊断、免疫治疗、放化疗疗效评估及预后预测。调节肠道菌群对于增强抗肿瘤治疗应答、提高患者生命质量、改善预后具有重要的临床价值。

Abstract:

The occurrence and progression of cervical cancer are influenced by gut flora. Patients with cervical cancer have different gut flora from healthy women，and the detection and evaluation of gut flora can help in the diagnosis，immunotherapy，assessment of radiotherapy efficacy and prognosis prediction of cervical cancer. Regulation of gut flora is of great clinical value in enhancing response to anti-tumor therapy，improving patients' quality of life and improving prognosis.

Key words: Uterine cervical neoplasms, Gastrointestinal microbiome, Chemoradiotherapy, Immunotherapy

吕璐, 孙鹏飞. 肠道菌群与宫颈癌[J]. 国际肿瘤学杂志, 2023, 50(6): 373-376.

Lyu Lu, Sun Pengfei. Gut flora and cervical cancer[J]. Journal of International Oncology, 2023, 50(6): 373-376.

参考文献 31

[1]	Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249. DOI: 10.3322/caac.21660. doi: 10.3322/caac.21660
[2]	Nishida A, Inoue R, Inatomi O, et al. Gut microbiota in the pathogenesis of inflammatory bowel disease[J]. Clin J Gastroenterol, 2018, 11(1): 1-10. DOI: 10.1007/s12328-017-0813-5. doi: 10.1007/s12328-017-0813-5 pmid: 29285689
[3]	Lee CJ, Sears CL, Maruthur N. Gut microbiome and its role in obesity and insulin resistance[J]. Ann N Y Acad Sci, 2020, 1461(1): 37-52. DOI: 10.1111/nyas.14107. doi: 10.1111/nyas.14107
[4]	Singer-Englar T, Barlow G, Mathur R. Obesity, diabetes, and the gut microbiome: an updated review[J]. Expert Rev Gastroenterol Hepatol, 2019, 13(1): 3-15. DOI: 10.1080/17474124.2019.1543023. doi: 10.1080/17474124.2019.1543023
[5]	Franzosa EA, Sirota-Madi A, Avila-Pacheco J, et al. Author correction: gut microbiome structure and metabolic activity in inflammatory bowel disease[J]. Nat Microbiol, 2019, 4(5): 898. DOI: 10.1038/s41564-019-0442-5. doi: 10.1038/s41564-019-0442-5 pmid: 30971771
[6]	Pimentel M, Lembo A. Microbiome and its role in irritable bowel syndrome[J]. Dig Dis Sci, 2020, 65(3): 829-839. DOI: 10.1007/s10620-020-06109-5. doi: 10.1007/s10620-020-06109-5
[7]	Sims TT, Colbert LE, Zheng J, et al. Gut microbial diversity and genus-level differences identified in cervical cancer patients versus healthy controls[J]. Gynecol Oncol, 2019, 155(2): 237-244. DOI: 10.1016/j.ygyno.2019.09.002. doi: S0090-8258(19)31489-1 pmid: 31500892
[8]	Kang GU, Jung DR, Lee YH, et al. Dynamics of fecal microbiota with and without invasive cervical cancer and its application in early diagnosis[J]. Cancers (Basel), 2020, 12(12): 3800. DOI: 10.3390/cancers12123800. doi: 10.3390/cancers12123800
[9]	Wang Z, Wang Q, Zhao J, et al. Altered diversity and composition of the gut microbiome in patients with cervical cancer[J]. AMB Express, 2019, 9(1): 40. DOI: 10.1186/s13568-019-0763-z. doi: 10.1186/s13568-019-0763-z pmid: 30904962
[10]	You L, Cui H, Zhao F, et al. Inhibition of HMGB1/RAGE axis suppressed the lipopolysaccharide (LPS)-induced vicious transformation of cervical epithelial cells[J]. Bioengineered, 2021, 12(1): 4995-5003. DOI: 10.1080/21655979.2021.1957750. doi: 10.1080/21655979.2021.1957750 pmid: 34369271
[11]	Karpinets TV, Solley TN, Mikkelson MD, et al. Effect of antibiotics on gut and vaginal microbiomes associated with cervical cancer development in mice[J]. Cancer Prev Res (Phila), 2020, 13(12): 997-1006. DOI: 10.1158/1940-6207.CAPR-20-0103. doi: 10.1158/1940-6207.CAPR-20-0103
[12]	Colombo N, Dubot C, Lorusso D, et al. Pembrolizumab for persistent, recurrent, or metastatic cervical cancer[J]. N Engl J Med, 2021, 385(20): 1856-1867. DOI: 10.1056/NEJMoa2112435. doi: 10.1056/NEJMoa2112435
[13]	Tewari KS, Monk BJ, Vergote I, et al. Survival with cemiplimab in recurrent cervical cancer[J]. N Engl J Med, 2022, 386(6): 544-555. DOI: 10.1056/NEJMoa2112187. doi: 10.1056/NEJMoa2112187
[14]	Baruch EN, Youngster I, Ben-Betzalel G, et al. Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients[J]. Science, 2021, 371(6529): 602-609. DOI: 10.1126/science.abb5920. doi: 10.1126/science.abb5920 pmid: 33303685
[15]	Davar D, Dzutsev AK, McCulloch JA, et al. Fecal microbiota transplant overcomes resistance to anti-PD-1 therapy in melanoma patients[J]. Science, 2021, 371(6529): 595-602. DOI: 10.1126/science.abf3363. doi: 10.1126/science.abf3363 pmid: 33542131
[16]	Matson V, Fessler J, Bao R, et al. The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients[J]. Science, 2018, 359(6371): 104-108. DOI: 10.1126/science.aao3290. doi: 10.1126/science.aao3290 pmid: 29302014
[17]	Sims TT, El Alam MB, Karpinets TV, et al. Gut microbiome diversity is an independent predictor of survival in cervical cancer patients receiving chemoradiation[J]. Commun Biol, 2021, 4(1): 237. DOI: 10.1038/s42003-021-01741-x. doi: 10.1038/s42003-021-01741-x pmid: 33619320
[18]	Che Y, Yang Y, Suo J, et al. Induction of systemic immune responses and reversion of immunosuppression in the tumor microenvironment by a therapeutic vaccine for cervical cancer[J]. Cancer Immunol Immunother, 2020, 69(12): 2651-2664. DOI: 10.1007/s00262-020-02651-3. doi: 10.1007/s00262-020-02651-3
[19]	Che Y, Fu S, Wang H, et al. Correlation of the gut microbiota and antitumor immune responses induced by a human papillomavirus therapeutic vaccine[J]. ACS Infect Dis, 2022, 8(12): 2494-2504. DOI: 10.1021/acsinfecdis.2c00305. doi: 10.1021/acsinfecdis.2c00305 pmid: 36342280
[20]	Abdolalipour E, Mahooti M, Gorji A, et al. Synergistic therapeutic effects of probiotic Lactobacillus casei TD-2 consumption on GM-CSF-induced immune responses in a murine model of cervical cancer[J]. Nutr Cancer, 2022, 74(1): 372-382. DOI: 10.1080/01635581.2020.1865419. doi: 10.1080/01635581.2020.1865419
[21]	Abdolalipour E, Mahooti M, Salehzadeh A, et al. Evaluation of the antitumor immune responses of probiotic Bifidobacterium bifidum in human papillomavirus-induced tumor model[J]. Microb Pathog, 2020, 145: 104207. DOI: 10.1016/j.micpath.2020.104207. doi: 10.1016/j.micpath.2020.104207
[22]	Fernandes A, Oliveira A, Soares R, et al. The effects of ionizing radiation on gut microbiota, a systematic review[J]. Nutrients, 2021, 13(9): 3025. DOI: 10.3390/nu13093025. doi: 10.3390/nu13093025
[23]	Liu J, Liu C, Yue J. Radiotherapy and the gut microbiome: facts and fiction[J]. Radiat Oncol, 2021, 16(1): 9. DOI: 10.1186/s13014-020-01735-9. doi: 10.1186/s13014-020-01735-9 pmid: 33436010
[24]	Sims TT, Colbert LE, Karpinets T, et al. Compositional and temporal changes of the gut microbiome in women with cervical cancer undergoing chemoradiation: does it predict response?[J]. Gynecol Oncol, 2020, 159, SUPPLEMENT 1: 35-36. DOI: 10.1016/j.ygyno.2020.06.074. doi: 10.1016/j.ygyno.2020.06.074
[25]	Uribe-Herranz M, Rafail S, Beghi S, et al. Gut microbiota modulate dendritic cell antigen presentation and radiotherapy-induced antitumor immune response[J]. J Clin Invest, 2020, 130(1): 466-479. DOI: 10.1172/JCI124332. doi: 10.1172/JCI124332 pmid: 31815742
[26]	Cui M, Xiao H, Luo D, et al. Circadian rhythm shapes the gut microbiota affecting host radiosensitivity[J]. Int J Mol Sci, 2016, 17(11): 1786. DOI: 10.3390/ijms17111786. doi: 10.3390/ijms17111786
[27]	Demers M, Dagnault A, Desjardins J. A randomized double-blind controlled trial: impact of probiotics on diarrhea in patients treated with pelvic radiation[J]. Clin Nutr, 2014, 33(5): 761-767. DOI: 10.1016/j.clnu.2013.10.015. doi: 10.1016/j.clnu.2013.10.015 pmid: 24200199
[28]	Jian Y, Zhang D, Liu M, et al. The impact of gut microbiota on radiation-induced enteritis[J]. Front Cell Infect Microbiol, 2021, 11: 586392. DOI: 10.3389/fcimb.2021.586392. doi: 10.3389/fcimb.2021.586392
[29]	Wang Z, Wang Q, Wang X, et al. Gut microbial dysbiosis is associated with development and progression of radiation enteritis during pelvic radiotherapy[J]. J Cell Mol Med, 2019, 23(5): 3747-3756. DOI: 10.1111/jcmm.14289. doi: 10.1111/jcmm.14289 pmid: 30908851
[30]	Mitra A, Grossman Biegert GW, Delgado AY, et al. Microbial diversity and composition is associated with patient-reported toxicity during chemoradiation therapy for cervical cancer[J]. Int J Radiat Oncol Biol Phys, 2020, 107(1): 163-171. DOI: 10.1016/j.ijrobp.2019.12.040. doi: 10.1016/j.ijrobp.2019.12.040
[31]	Bai J, Barandouzi ZA, Rowcliffe C, et al. Gut microbiome and its associations with acute and chronic gastrointestinal toxicities in cancer patients with pelvic radiation therapy: a systematic review[J]. Front Oncol, 2021, 11: 745262. DOI: 10.3389/fonc.2021.745262. doi: 10.3389/fonc.2021.745262